) for the configuration, and then click Edit.In this section Hide
1. Click Settings.
The Settings page appears.
2. From the Configure System section, click Manage Drug Profile Configurations.
The Manage Drug Profile Configurations page appears
3. To add a new configuration, click Add Drug Profile Configuration.
The Add Drug Profile Configuration page appears.
or
To edit a configuration, click the row menu () for the configuration, and then click Edit.
The Edit Drug Profile Configuration page appears.
4. If your organization uses signal management from the Signal Management Configuration drop-down list, select a signal configuration.
When the drug profile configuration and the specified signal configuration are both in use by a user and that user has a drug layout set as a user preference, then drug names on the Drug Overviews page (on the Signals tab) are links that go to the Drugs tab.
Note: Regardless of the drug type on the Drug Overviews page, the drug is considered by the Drugs tab to be a generic name. Thus, only the generic name settings in the drug profile configuration are used.
5. For each section on the page, you can specify report outputs and runs that you created or that are published to you. (If you have the Administer Users permission, you can also specify unpublished report outputs and runs created by any users in your login group.) For any report outputs and runs that you can specify, you can also specify any existing aliases for them.
6. Click Next.
The Save Drug Profile Configuration page appears.
7. Enter or edit the name and description of the drug profile configuration.
8. To save the drug profile configuration, click OK.
The Manage Drug Profile Configurations page appears. If you created a drug profile configuration it appears as the bottom row.
The data mining runs that you reference in a drug profile configuration must have an item variable with the subtype Generic, Trade, or Ingredient (depending on the section of the drug profile configuration) in the data configuration.
Lists of available report outputs and data mining runs also include aliases for those objects. If the drug profile configuration refers to an alias, the alias is resolved each time a user goes to the Drugs tab. This is useful if updates of data and new data mining runs are expected, and you want charts for those new runs to be available on the Drugs tab.
For example, the drug profile configuration refers to an alias named, Latest 2D Generic. The alias can be updated to point to new data mining runs, but the drug profile configuration does not need to be updated and users do not need to set their user preference to a new drug profile configuration.
Note: Users of the Drugs tab can view charts for all report outputs and data mining runs that are referenced by their current drug profile configuration, regardless of whether or not they can view the report outputs or runs elsewhere in the application
When defining a drug profile configuration, consider which data configurations the data mining runs and report outputs that you reference are based on.
Another consideration is that when users select drugs when adding a chart (on the Drugs tab), the list of available drugs can differ depending on the type of chart. For example, suppose that the 2D run results, but not the 3D run results, include custom terms. When selecting drugs for an EBGM graph, but not for a nested confidence interval graph, users are able to select custom terms (the nested interval graph applies only to results for the 3D run). For consistency of available drugs that can be selected for various chart types, the drug profile configuration should reference similarly constructed data mining runs.
Users can also select drugs from the Drug menu. In constructing the list of available drugs that can be selected from the Drug menu, the application uses the following objects, in order of precedence: